Dow Up0.07% Nasdaq Up0.61%

Auxilium Pharmaceuticals Inc. (AUXL)

-NasdaqGS
34.28 Up 0.09(0.26%) Nov 26, 4:00PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
Total Revenue 109,624   83,018   88,519   125,884  
Cost of Revenue25,713  30,094  18,094  36,157  
Gross Profit 83,911   52,924   70,425   89,727  
Operating Expenses
Research Development11,222  11,303  10,994  12,911  
Selling General and Administrative59,658  48,807  85,733  72,644  
Non Recurring16,514   -   -   -  
Others19,713  19,970  19,761  19,008  
Total Operating Expenses107,107   -   -   -  
Operating Income or Loss (23,196) (27,156) (46,063) (14,836)
Income from Continuing Operations
Total Other Income/Expenses Net22  56  (56)110  
Earnings Before Interest And Taxes(23,174)(27,100)(46,119)(14,726)
Interest Expense9,577  9,513  9,520  9,605  
Income Before Tax(32,751)(36,613)(55,639)(24,331)
Income Tax Expense(101)(118)338  (377)
Minority Interest -   -   -   -  
Net Income From Continuing Ops(32,650)(36,495)(55,977)(23,954)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (32,650) (36,495) (55,977) (23,954)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (32,650) (36,495) (55,977) (23,954)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.